ShuYWangLWangYTanJZhangHYangY.Association between anemia and prognosis in patients with acute coronary syndrome and atrial fibrillation. Angiology. 2026;77:592-601.
2.
SabatineMSMorrowDAGiuglianoRP, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation. 2005;111:2042-2049.
3.
WestenbrinkBDAlingsMConnollySJ, et al. Anemia predicts thromboembolic events, bleeding complications, and mortality in patients with atrial fibrillation. J Thromb Haemost. 2015;13:699-707.
4.
MamasMAKwokCSKontopantelisE, et al. Relationship between anemia and mortality outcomes in a national acute coronary syndrome cohort: insights from the UK Myocardial Ischemia National Audit Project Registry. J Am Heart Assoc. 2016;5:e003348.
5.
NikolskyEAymongEDHalkinA, et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol. 2004;44:547-553.
6.
JankowskaEAPonikowskiP.Molecular changes in myocardium in the course of anemia or iron deficiency. Heart Fail Clin. 2010;6:295-304.
7.
PencinaMJD’AgostinoRBSrSteyerbergEW.Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11-21.
8.
WestenbrinkBDAlingsMGrangerCB, et al. Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Am Heart J. 2017;185:140-149.
9.
UrbanPMehranRColleranR, et al. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk. Eur Heart J. 2019;40:2632-2653.
